Indian pharmaceutical company Dr. Reddy Laboratories reported a cyber attack about a week after the company was granted permission to begin its final stage trials for a Russian COVID-19 vaccine.
In a statement released by Dr. Reddy’s to the National Stock Exchange of India, Chief Information Officer Mukesh Rathi said the company had isolated all data centers services and took required preventive actions. Rathi added that Dr. Reddy’s anticipated that all services would be up within 24 hours and does not believe the incident will have any major impact on its operations.
Saryu Nayyar, CEO at Gurucul, said the breach against India’s Dr. Reddy Laboratories again shows that there’s no sector of industry that’s safe from attack.
Please register to continue.
Already registered? Log in.
Once you register, you'll receive:
The context and insight you need to stay abreast of the most important developments in cybersecurity. CISO and practitioner perspectives; strategy and tactics; solutions and innovation; policy and regulation.
Unlimited access to nearly 20 years of SC Media industry analysis and news-you-can-use.
SC Media’s essential morning briefing for cybersecurity professionals.
One-click access to our extensive program of virtual events, with convenient calendar reminders and ability to earn CISSP credits.